Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 603-309-4 | CAS number: 128973-77-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- other toxicological threshold
- Value:
- 220 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- other: Category specific approach
- Overall assessment factor (AF):
- 9
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 1 987 mg/m³
- Explanation for the modification of the dose descriptor starting point:
- Correction of NOAEL oral to inhaled: 1127*(1/0.38m3/kg)*(6.7m3/10m3)*1=1987 mg/m3
- AF for dose response relationship:
- 1
- Justification:
- Default
- AF for differences in duration of exposure:
- 1.5
- Justification:
- Exposure duration of the study does not have great impact on the NOAEL. A rat and dog 13 week, 26 week and 52 week studies have all NOAEL of around 1000 mg/kg bw. Time extrapolation for sub-chronic to chronic, has a default factor of 2. Given the evidence in two species, it is reasonable to deviate from the default factor of 2, and propose a specific LCA exposure duration factor of 1.5
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Oral to inhaled ECETOC default. Refer to Justification for interspecies difference
- AF for other interspecies differences:
- 2
- Justification:
- Similar NOAELs indicate low variability between species. Dietary doses are adjusted for body weight differences during the study, hence allometry is implicit when comparing NOAELs from studies on two species. Since NOAELs in rat and dog studies are comparable, it is reasonable to assume that extrapolation to human will require a lower assessment factor. The default interspecies extrapolation factor for rat to human is 4, and 1.5 for dog. A specific LCA interspecies assessment factor of 2 is proposed.
- AF for intraspecies differences:
- 3
- Justification:
- ECETOC default
- AF for the quality of the whole database:
- 1
- Justification:
- Reliable studies
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties
Acute/short term exposure
- Hazard assessment conclusion:
- other toxicological threshold
- Value:
- 220 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL extrapolated from long term DNEL
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
- Most sensitive endpoint:
- acute toxicity
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
- Most sensitive endpoint:
- acute toxicity
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- other toxicological threshold
- Value:
- 125 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- other: Category specific approach
- Overall assessment factor (AF):
- 9
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 1 127 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
- Oral NOAEL = corrected dermal NOAEL
- AF for dose response relationship:
- 1
- Justification:
- Default
- AF for differences in duration of exposure:
- 1.5
- Justification:
- Exposure duration of the study does not have great impact on the NOAEL. A rat and dog 13 week, 26 week and 52 week studies have all NOAEL of around 1000 mg/kg bw. Time extrapolation for sub-chronic to chronic, has a default factor of 2. Given the evidence in two species, it is reasonable to deviate from the default factor of 2, and propose a specific LCA exposure duration factor of 1.5
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Oral to dermal ECETOC default. Refer to Justification for interspecies difference
- AF for other interspecies differences:
- 2
- Justification:
- Similar NOAELs indicate low variability between species. Dietary doses are adjusted for body weight differences during the study, hence allometry is implicit when comparing NOAELs from studies on two species. Since NOAELs in rat and dog studies are comparable, it is reasonable to assume that extrapolation to human will require a lower assessment factor. The default interspecies extrapolation factor for rat to human is 4, and 1.5 for dog. A specific LCA interspecies assessment factor of 2 is proposed.
- AF for intraspecies differences:
- 3
- Justification:
- ECETOC default
- AF for the quality of the whole database:
- 1
- Justification:
- Reliable studies
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties
Acute/short term exposure
- Hazard assessment conclusion:
- other toxicological threshold
- Value:
- 125 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL extrapolated from long term DNEL
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
- Most sensitive endpoint:
- skin irritation/corrosion
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
- Most sensitive endpoint:
- skin irritation/corrosion
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Additional information - workers
Chronic and sub-chronic toxicity studies have shown that long chain alcohols (LCA) are of low toxicity. Furthermore, combined repeated-dose studies with developmental endpoints, as well as reproductive and developmental studies showed no effects at the highest dose tested.
Rather than having separate values for the three endpoints, one endpoint, systemic effects, has been used instead. Since the NOAELs do not vary greatly across the category, one key study has been chosen as being representative of the whole category.
C6, Hexanol has been chosen as the category representative because shorter chain molecules are usually regarded as more toxic when compared to structural analogues with longer carbon chain lengths. The 13-week repeat dose study on 1-hexanol by (Sc. Assoc. 1966) has been used as the key study for deriving the Indicative Human No Effect Level (IHNEL) for LCA category. This study reported a NOAEL of 1127 mg/kg (bw).
In some cases the CAS and chemical identity stated refer to SDA nomenclature for this substance. in REACH substance identification it is necessary to be more specific as to the chain lengths present. Full details may be found in the CSR.
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- other toxicological threshold
- Value:
- 65 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- other: Category specific approach
- Overall assessment factor (AF):
- 15
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 980 mg/m³
- Explanation for the modification of the dose descriptor starting point:
- Correction of NOAEL oral to inhaled: 1127*(1/1.15m3/kg)*1=980 mg/m3
- AF for dose response relationship:
- 1
- Justification:
- Default
- AF for differences in duration of exposure:
- 1.5
- Justification:
- Exposure duration of the study does not have great impact on the NOAEL. A rat and dog 13 week, 26 week and 52 week studies have all NOAEL of around 1000 mg/kg bw. Time extrapolation for sub-chronic to chronic, has a default factor of 2. Given the evidence in two species, it is reasonable to deviate from the default factor of 2, and propose a specific LCA exposure duration factor of 1.5
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Oral to inhaled ECETOC default. Refer to Justification for interspecies difference
- AF for other interspecies differences:
- 2
- Justification:
- Similar NOAELs indicate low variability between species. Dietary doses are adjusted for body weight differences during the study, hence allometry is implicit when comparing NOAELs from studies on two species. Since NOAELs in rat and dog studies are comparable, it is reasonable to assume that extrapolation to human will require a lower assessment factor. The default interspecies extrapolation factor for rat to human is 4, and 1.5 for dog. A specific LCA interspecies assessment factor of 2 is proposed.
- AF for intraspecies differences:
- 5
- Justification:
- ECETOC default
- AF for the quality of the whole database:
- 1
- Justification:
- Reliable studies
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties
Acute/short term exposure
- Hazard assessment conclusion:
- other toxicological threshold
- Value:
- 65 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL extrapolated from long term DNEL
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
- Most sensitive endpoint:
- acute toxicity
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
- Most sensitive endpoint:
- acute toxicity
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- other toxicological threshold
- Value:
- 75 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- other: Category specific approach
- Overall assessment factor (AF):
- 15
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 1 127 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
- Oral NOAEL =corrected dermal NOAEL
- AF for dose response relationship:
- 1
- Justification:
- Default
- AF for differences in duration of exposure:
- 1.5
- Justification:
- Exposure duration of the study does not have great impact on the NOAEL. A rat and dog 13 week, 26 week and 52 week studies have all NOAEL of around 1000 mg/kg bw. Time extrapolation for sub-chronic to chronic, has a default factor of 2. Given the evidence in two species, it is reasonable to deviate from the default factor of 2, and propose a specific LCA exposure duration factor of 1.5
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Oral to dermal ECETOC default. Refer to Justification for interspecies difference
- AF for other interspecies differences:
- 2
- Justification:
- Similar NOAELs indicate low variability between species. Dietary doses are adjusted for body weight differences during the study, hence allometry is implicit when comparing NOAELs from studies on two species. Since NOAELs in rat and dog studies are comparable, it is reasonable to assume that extrapolation to human will require a lower assessment factor. The default interspecies extrapolation factor for rat to human is 4, and 1.5 for dog. A specific LCA interspecies assessment factor of 2 is proposed.
- AF for intraspecies differences:
- 5
- Justification:
- ECETOC default
- AF for the quality of the whole database:
- 1
- Justification:
- Reliable studies
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
- Most sensitive endpoint:
- skin irritation/corrosion
- Route of original study:
- Dermal
DNEL related information
- DNEL extrapolated from long term DNEL
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
- Most sensitive endpoint:
- skin irritation/corrosion
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
- Most sensitive endpoint:
- skin irritation/corrosion
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- other toxicological threshold
- Value:
- 75 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- other: Category specific approach
- Overall assessment factor (AF):
- 15
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 1 127 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
- Oral NOAEL
- AF for dose response relationship:
- 1
- Justification:
- Default
- AF for differences in duration of exposure:
- 1.5
- Justification:
- Exposure duration of the study does not have great impact on the NOAEL. A rat and dog 13 week, 26 week and 52 week studies have all NOAEL of around 1000 mg/kg bw. Time extrapolation for sub-chronic to chronic, has a default factor of 2. Given the evidence in two species, it is reasonable to deviate from the default factor of 2, and propose a specific LCA exposure duration factor of 1.5
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Oral to oral. Refer to Justification for interspecies difference
- AF for other interspecies differences:
- 2
- Justification:
- Similar NOAELs indicate low variability between species. Dietary doses are adjusted for body weight differences during the study, hence allometry is implicit when comparing NOAELs from studies on two species. Since NOAELs in rat and dog studies are comparable, it is reasonable to assume that extrapolation to human will require a lower assessment factor. The default interspecies extrapolation factor for rat to human is 4, and 1.5 for dog. A specific LCA interspecies assessment factor of 2 is proposed.
- AF for intraspecies differences:
- 5
- Justification:
- ECETOC default
- AF for the quality of the whole database:
- 1
- Justification:
- Reliable studies
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties
Acute/short term exposure
- Hazard assessment conclusion:
- other toxicological threshold
- Value:
- 75 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL extrapolated from long term DNEL
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Additional information - General Population
Chronic and sub-chronic toxicity studies have shown that long chain alcohols (LCA) are of low toxicity. Furthermore, combined repeated-dose studies with developmental endpoints, as well as reproductive and developmental studies showed no effects at the highest dose tested.
Rather than having separate values for the three endpoints, one endpoint ¿systemic effects¿ has been used instead. Since the NOAELs do not vary greatly across the category, one key study has been chosen as being representative of the whole category.
C6, Hexanol has been chosen as the category representative because shorter chain molecules are usually regarded as more toxic when compared to structural analogues with longer carbon chain lengths. The 13-week repeat dose study on 1-hexanol by (Sc. Assoc. 1966) has been used as the key study for deriving the Indicative Human No Effect Level (IHNEL) for LCA category. This study reported a NOAEL of 1127 mg/kg (bw).
In some cases the CAS and chemical identity stated refer to SDA nomenclature for this substance. in REACH substance identification it is necessary to be more specific as to the chain lengths present. Full details may be found in the CSR.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.